|
|
||||||||
The Journal of Neurophysiology Vol. 82 No. 4 October 1999, pp. 1776-1785
Copyright ©1999 by the American Physiological Society
The Scripps Research Institute, Department of Neuropharmacology, La Jolla, California 92037
Madamba, Samuel G.,
Paul Schweitzer, and
George Robert Siggins.
Nociceptin Augments K+ Currents in Hippocampal CA1
Neurons by Both ORL-1 and Opiate Receptor Mechanisms. J. Neurophysiol. 82: 1776-1785, 1999. We previously
reported (see also the accompanying paper) that dynorphin A
significantly enhanced the voltage-dependent K+ M-current
(IM) in CA3 and CA1 hippocampal pyramidal
neurons (HPNs). Because the opioid-receptor-like-1 (ORL-1) receptor
shares a high sequence homology with opioid receptors and is expressed
in rat hippocampus, we examined the effects of orphanin FQ or
nociceptin, the endogenous ligand for the ORL-1 receptor, using the rat
hippocampal slice preparation and intracellular voltage-clamp
recording. Current-voltage (I-V) relationships from CA1
HPNs revealed that nociceptin superfusion induced an outward current
reversing near the equilibrium potential for K+ ions.
Ba2+ (2 mM) blocked this effect. The nociceptin-induced
current was largest at depolarized membrane potentials, where
IM is largely activated. Nociceptin
concentrations of 0.5-1 µM (but not 0.1 µM) significantly
increased IM relaxation amplitudes with
recovery on washout. Interestingly, both the general opiate antagonist naloxone and the
receptor antagonist nor-binaltorphimine (nBNI) inhibited the nociceptin-induced IM
increases and outward currents in the depolarized range but not the
inward current induced at hyperpolarized potentials. The putative ORL-1
receptor antagonist, [Phe1
(CH2-NH)Gly2]NC(1-13)NH2
(hereafter ORLAn), blocked most of the nociceptin current near rest but
not the IM increase. However, ORLAn alone had direct effects similar to those of nociceptin, indicating that
ORLAn might be a partial agonist. Our results suggest that nociceptin
postsynaptically modulates the excitability of HPNs through ORL-1 and
-like opiate receptors linked to different K+ channels.
This article has been cited by other articles:
![]() |
M. Roberto and G. R. Siggins Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala PNAS, June 20, 2006; 103(25): 9715 - 9720. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Meis Nociceptin/Orphanin FQ: Actions within the Brain Neuroscientist, April 1, 2003; 9(2): 158 - 168. [Abstract] [PDF] |
||||
![]() |
M. V. Baratta, T. Lamp, and M. K. Tallent Somatostatin Depresses Long-Term Potentiation and Ca2+ Signaling in Mouse Dentate Gyrus J Neurophysiol, December 1, 2002; 88(6): 3078 - 3086. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bregola, S. Zucchini, D. Rodi, A. Binaschi, C. D'Addario, D. Landuzzi, R. Reinscheid, S. Candeletti, P. Romualdi, and M. Simonato Involvement of the Neuropeptide Nociceptin/Orphanin FQ in Kainate Seizures J. Neurosci., November 15, 2002; 22(22): 10030 - 10038. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Chin, K. Harris, D. MacTavish, and J. H. Jhamandas Nociceptin/Orphanin FQ Modulation of Ionic Conductances in Rat Basal Forebrain Neurons J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 188 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Tallent, S. G. Madamba, and G. R. Siggins Nociceptin Reduces Epileptiform Events in CA3 Hippocampus via Presynaptic and Postsynaptic Mechanisms J. Neurosci., September 1, 2001; 21(17): 6940 - 6948. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |